ArticleMolecular cancer therapeutics2023

Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood Sarcoma.

Terry J Shackleford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.